DECLARE-TIMI 58 trial in the context of EMPA-REG OUTCOME and CANVAS
The article discussed results of the DECLARE-TIMI 58 study in the aspects of the previously finished trials (EMPA-REG OUTCOME and CANVAS). All three SGLT2i demonstrated the reduction of the risk of hospitalization for heart failure, as well as the risk of progression chronic kidney disease. At the s...
| Κύριος συγγραφέας: | |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
Endocrinology Research Centre
2019-12-01
|
| Σειρά: | Сахарный диабет |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.dia-endojournals.ru/jour/article/view/10289 |